Global Glycated Albumin Assay Market Size Study & Forecast, by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes) by End User (Hospitals & Diabetic Care Centers, Diagnostic Laboratories) and Regional Forecasts 2025-2035

Description

The Global Glycated Albumin Assay Market is valued at approximately USD 1.19 billion in 2024 and is projected to grow at a robust CAGR of 8.90% during the forecast period 2025-2035. Glycated albumin assays are advanced diagnostic tools used to monitor short-term glycemic control, providing critical insights into blood sugar fluctuations over a period of 2-4 weeks. These assays are increasingly adopted for assessing prediabetes, managing type 1 and type 2 diabetes, and complementing traditional HbA1c measurements. The growth of the market is propelled by the escalating prevalence of diabetes worldwide, rising awareness regarding the importance of continuous glucose monitoring, and advances in assay sensitivity and specificity. Moreover, increasing healthcare expenditure, enhanced laboratory infrastructure, and the growing emphasis on early diagnosis and preventive care are significant contributors to market expansion.

The rising burden of diabetes across the globe has triggered a surge in demand for glycated albumin assays. These assays offer advantages over conventional glucose monitoring methods, particularly in cases where HbA1c readings may be unreliable due to conditions like anemia or hemoglobinopathies. According to global health statistics, the number of adults living with diabetes is projected to reach over 700 million by 2035, amplifying the need for accurate and timely diagnostics. Additionally, the proliferation of advanced assay platforms and automated testing solutions provides lucrative opportunities for market participants. Nevertheless, high assay costs and stringent regulatory frameworks may temper market growth during the forecast period 2025-2035.

The detailed segments and sub-segments included in the report are:

By Application:

Prediabetes
Type 1 Diabetes
Type 2 Diabetes

By End User:

Hospitals & Diabetic Care Centers
Diagnostic Laboratories

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
RoE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Type 2 Diabetes Segment Expected to Dominate the Market

The type 2 diabetes segment is anticipated to dominate the glycated albumin assay market, accounting for the largest share due to the widespread prevalence of type 2 diabetes among adults. Increased awareness of early diagnosis, coupled with rising healthcare screening initiatives, has propelled adoption of these assays in clinical settings. Prediabetes monitoring is also gaining traction as healthcare providers prioritize preventive strategies, though its market share remains comparatively moderate.

Hospitals & Diabetic Care Centers Lead in Revenue Contribution

When segmented by end user, hospitals and diabetic care centers currently generate the highest revenue, benefiting from their expansive patient base and routine monitoring protocols. Diagnostic laboratories are experiencing steady growth, driven by rising demand for specialized testing services, automation, and advanced assay platforms. This delineates a market where hospitals dominate in revenue, while laboratories accelerate adoption through technology-driven enhancements.

North America dominated the market in 2025 due to a well-established healthcare ecosystem, advanced diagnostic infrastructure, and widespread awareness of diabetes management. Europe follows closely, supported by proactive government initiatives, reimbursement policies, and clinical adoption of glycated albumin assays. Asia Pacific is projected to be the fastest-growing region over the forecast period, fueled by rising diabetes prevalence, growing healthcare expenditure, and expanding laboratory networks in countries such as China and India. Latin America and the Middle East & Africa are emerging markets, driven by increasing awareness and infrastructure development in urban healthcare facilities.

Major market players included in this report are:

Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Bio-Rad Laboratories
Arkray, Inc.
Beckman Coulter, Inc.
Diazyme Laboratories
EKF Diagnostics
Tosoh Bioscience
MedTest DX
Randox Laboratories
Mindray Medical International
Diazyme, Inc.
Diazyme Laboratories, Inc.
Medtronic

Global Glycated Albumin Assay Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of the geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Glycated Albumin Assay Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Glycated Albumin Assay Market Forces Analysis

3.1. Market Forces Shaping The Global Glycated Albumin Assay Market (2024-2035)
3.2. Drivers
- 3.2.1. escalating prevalence of diabetes worldwide
- 3.2.2. rising awareness regarding the importance of continuous glucose monitoring
3.3. Restraints
- 3.3.1. high assay costs and stringent regulatory frameworks
3.4. Opportunities
- 3.4.1. increasing healthcare expenditure, enhanced laboratory infrastructure, and the growing emphasis on early diagnosis and preventive care

Chapter 4. Global Glycated Albumin Assay Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Glycated Albumin Assay Market Size & Forecasts by Application 2025-2035

5.1. Market Overview
5.2. Global Glycated Albumin Assay Market Performance - Potential Analysis (2025)
5.3. Prediabetes
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Type 1 Diabetes
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Type 2 Diabetes
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Glycated Albumin Assay Market Size & Forecasts by End User 2025-2035

6.1. Market Overview
6.2. Global Glycated Albumin Assay Market Performance - Potential Analysis (2025)
6.3. Hospitals & Diabetic Care Centers
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Diagnostic Laboratories
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Glycated Albumin Assay Market Size & Forecasts by Region 2025-2035

7.1. Growth Glycated Albumin Assay Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Glycated Albumin Assay Market
- 7.3.1. U.S. Glycated Albumin Assay Market
  - 7.3.1.1. Application breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End User breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Glycated Albumin Assay Market
  - 7.3.2.1. Application breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End User breakdown size & forecasts, 2025-2035
7.4. Europe Glycated Albumin Assay Market
- 7.4.1. UK Glycated Albumin Assay Market
  - 7.4.1.1. Application breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End User breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Glycated Albumin Assay Market
  - 7.4.2.1. Application breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End User breakdown size & forecasts, 2025-2035
- 7.4.3. France Glycated Albumin Assay Market
  - 7.4.3.1. Application breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End User breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Glycated Albumin Assay Market
  - 7.4.4.1. Application breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End User breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Glycated Albumin Assay Market
  - 7.4.5.1. Application breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End User breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Glycated Albumin Assay Market
  - 7.4.6.1. Application breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End User breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Glycated Albumin Assay Market
- 7.5.1. China Glycated Albumin Assay Market
  - 7.5.1.1. Application breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End User breakdown size & forecasts, 2025-2035
- 7.5.2. India Glycated Albumin Assay Market
  - 7.5.2.1. Application breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End User breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Glycated Albumin Assay Market
  - 7.5.3.1. Application breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End User breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Glycated Albumin Assay Market
  - 7.5.4.1. Application breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End User breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Glycated Albumin Assay Market
  - 7.5.5.1. Application breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End User breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Glycated Albumin Assay Market
  - 7.5.6.1. Application breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End User breakdown size & forecasts, 2025-2035
7.6. Latin America Glycated Albumin Assay Market
- 7.6.1. Brazil Glycated Albumin Assay Market
  - 7.6.1.1. Application breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End User breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Glycated Albumin Assay Market
  - 7.6.2.1. Application breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End User breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Glycated Albumin Assay Market
- 7.7.1. UAE Glycated Albumin Assay Market
  - 7.7.1.1. Application breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End User breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Glycated Albumin Assay Market
  - 7.7.2.1. Application breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End User breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Glycated Albumin Assay Market
  - 7.7.3.1. Application breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End User breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Roche Diagnostics
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Abbott Laboratories
8.4. Siemens Healthineers
8.5. Bio-Rad Laboratories
8.6. Arkray, Inc.
8.7. Beckman Coulter, Inc.
8.8. Diazyme Laboratories
8.9. EKF Diagnostics
8.10. Tosoh Bioscience
8.11. MedTest DX
8.12. Randox Laboratories
8.13. Mindray Medical International
8.14. Diazyme, Inc.
8.15. Diazyme Laboratories, Inc.
8.16. Medtronic